← Leaderboards
Zachary Rome
Patagonia Pharmaceuticals, Llc
$1,622,787
Attributed
$1,622,787
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $624.1K · FY2018–21$1M$750K$500K$250K$0
'18
'19
'20
'21
Funding mix
By agency
FDA$1,622,787 · 1
By mechanism
R01$1,622,787 · 1
Top collaborators
No co-investigators on record.
Grant awards (5)
Ph2.Study of PAT-001 for Treatment of Congenital Ichthyosis IND122058(7/27/2016)$499,580
R01 · FY2021 · FD · contact PI
Ph2.Study of PAT-001 for Treatment of Congenital Ichthyosis IND122058(7/27/2016)$124,519
R01 · FY2021 · FD · contact PI
Ph2.Study of PAT-001 for Treatment of Congenital Ichthyosis IND122058(7/27/2016)$499,709
R01 · FY2020 · FD · contact PI
Ph2.Study of PAT-001 for Treatment of Congenital Ichthyosis IND122058(7/27/2016)$274,510
R01 · FY2018 · FD · contact PI
Ph2.Study of PAT-001 for Treatment of Congenital Ichthyosis IND122058(7/27/2016)$224,469
R01 · FY2018 · FD · contact PI